On August 4, 2016, Pennsylvania Secretary of Health, Dr. Karen Murphy, announced that John J. Collins had been named the director of the Office of Medical Marijuana. Collins is in an internal appointment from the Department of Health. Collins joined the Department of Health in April of this year and currently serves as a public health program assistant administrator in the Division of HIV Disease.
According to the DOH’s press release, Collins will be responsible for guiding the implementation of the state’s medical marijuana program, which is expected to be complete by early 2018. The DOH states Collins is a certified allied health professional and holds an MBA with a concentration in marketing from Lindenwood University. Collins also completed leadership training at the Wharton School, Aresty Institute of Executive Education, University of Pennsylvania. Collins also has extensive executive experience in the private sector, most recently as chief operating officer for Triad Isotopes, Inc., in Orlando, Florida.
According to Collins his has “experience in a heavily regulated medical enterprise, market research and new product development, strategic planning, logistics, communications, and customer service is a perfect fit for the requirements of overseeing the implementation of Pennsylvania’s Medical Marijuana Program.”
Collins will assume his new role on August 8, 2016.